Download Free Sample Report

This report contains market size and forecasts of Fostamatinib in global, including the following market information:

• Global Fostamatinib Market Revenue, 2018-2023, 2023-2030, ($ millions)
• Global Fostamatinib Market Sales, 2018-2023, 2023-2030, (K Bottles)
• Global top five Fostamatinib companies in 2022 (%)

The global Fostamatinib market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Tavalisse Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Fostamatinib include Rigel Pharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, Grifols, JW Pharmaceutical Corporation, Medison Pharma Canada and AstraZeneca, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Fostamatinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fostamatinib Market, by Brand, 2018-2023, 2023-2030 ($ Millions) & (K Bottles)
Global Fostamatinib Market Segment Percentages, by Brand, 2022 (%)

• Tavalisse
• Tavlesse

Global Fostamatinib Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Bottles)
Global Fostamatinib Market Segment Percentages, by Application, 2022 (%)

• Idiopathic (Immune) Thrombocytopenic Purpura
• Waldenstrm's Macroglobulinemia
• Autoimmune Haemolytic Anaemia
• Other

Global Fostamatinib Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Bottles)
Global Fostamatinib Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Fostamatinib revenues in global market, 2018-2023 (Estimated), ($ millions)
• Key companies Fostamatinib revenues share in global market, 2022 (%)
• Key companies Fostamatinib sales in global market, 2018-2023 (Estimated), (K Bottles)
• Key companies Fostamatinib sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Rigel Pharmaceuticals, Inc
• Kissei Pharmaceutical Co., Ltd
• Grifols
• JW Pharmaceutical Corporation
• Medison Pharma Canada
• AstraZeneca